Nomura Holdings
FOLD

Nomura Holdings’s Amicus Therapeutics FOLD Stock Holding History

Nomura Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-151,300
Closed -$1.19M – 1991
2025
Q3 		$1.19M Buy
151,300
+101,300
+203% +$721K ﹤0.01% 1340
2025
Q2 		$287K Hold
50,000
– – ﹤0.01% 1248
2025
Q1 		$408K Buy
+50,000
New +$463K ﹤0.01% 1535

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nomura Holdings's FOLD Position: Q2 2025 in Review

Nomura Holdings sold out of Amicus Therapeutics (FOLD) in Q2 2025, closing a stake of 22,168 shares — an estimated $143K sold.

Nomura Holdings first reported a position in FOLD in Q2 2013 and held it in 14 quarters. The position peaked at $2.88M in Q3 2017. 272 funds tracked by Wall St. Rank hold FOLD as of Q2 2025.

  • Nomura Holdings reported no remaining Amicus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nomura Holdings sold 22,168 Amicus Therapeutics shares in Q2 2025, an estimated $143K.
  • Nomura Holdings first reported a position in Amicus Therapeutics in Q2 2013 and held it in 14 quarters.
  • Nomura Holdings's Amicus Therapeutics position peaked at $2.88M in Q3 2017.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.